Mesalazine in left-sided ulcerative colitis: Efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing

Current misunderstandings in the management of ulcerative colitis

(2011) T. Ochsenkuhn et al.   GUT

Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis

(2010) W. Kruis et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Topical agents for idiopathic distal colitis and proctitis

(2010) Ian Craig Lawrance   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX®with Asacol®

(2009) C. PRANTERA et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis

(2009) Axel U. Dignass et al.   Clinical Gastroenterology and Hepatology

Controversies in mucosal healing in ulcerative colitis

(2009) Sunanda Kane et al.   INFLAMMATORY BOWEL DISEASES

Importance of mucosal healing in ulcerative colitis

(2009) Gary R. Lichtenstein et al.   INFLAMMATORY BOWEL DISEASES

P169 - Higher remission rates in patients with once-daily dosing compared to twice-daily dosing. An analysis of compliance in the once daily vs. twice daily podium trial with mesalazine (Pentasa®) sachets

(2009) B. Bokemeyer et al.   Journal of Crohns & Colitis

Clinical implications of mucosal healing for the management of IBD

(2009) Guillaume Pineton de Chambrun et al.   Nature Reviews Gastroenterology & Hepatology

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis

(2008) M A Kamm et al.   GUT

European evidence-based Consensus on the management of ulcerative colitis: Current management

(2008) S.P.L. Travis et al.   Journal of Crohns & Colitis